Bayer Pharma AG

Vitamin K Antagonist, Warfarin, Warfarin Therapy

Vitamin K Antagonist

Vitamin K is essential for the hepatic synthesis of Factors II (prothrombin), VII, IX, and X, as well as protein C and protein S.100, 379 Antagonists of vitamin K have been used as anticoagulants for over 50 years.

The most widely used medications for treating thrombosis are heparins and vitamin K antagonists (VKAs). These medications have proven efficacy, but lack many properties of an ideal anticoagulant.

Learn more about vitamin k antagonist.


Warfarin, a synthetic derivative of coumarin, is the most commonly used vitamin K antagonist (VKA) in the United States. In some European countries, other coumarin derivatives (phenprocoumon and acenocoumarol) are used as an alternative to warfarin.372, 380

Learn more about warfarin.

Warfarin Therapy

Treatment with warfarin for four weeks to twelve months has been shown to reduce the risk of DVT recurrence by 90%. One exception to this general approach is the cancer patient with DVT, in whom long-term treatment (or therapy) with warfarin is less effective in preventing recurrence. LMWH, shown in one study to be roughly twice as effective in preventing this outcome, should be considered in these patients.299

Learn more about warfarin therapy.

Find out more about vitamin K antagonist, warfarin, and warfarin therapy.

See also: Apixaban

See also: DVT Symptom

Where to next?

People who read this article, also read these articles: